abilify aripiprazole 2mg tablet blister pack
otsuka australia pharmaceutical pty ltd - aripiprazole, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; microcrystalline cellulose; hyprolose; colour - - abilify is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. - acute treatment of manic or mixed episodes associated with bipolar i disorder in adults as monotherapy and in combination with lithium or valproate; - maintenance treatment of manic or mixed episodes in bipolar i disorder in adults as monotherapy.
otsuka pocone infrared spectrophotometer
nagase singapore (pte) ltd. - microbiology - an in vitro diagnostic device to measure changes in 13co2 content in breath co2 gas by infrared spectroscopic analysis. intended for use in conjunction with commercially available 13c-urea breath tests for the detection of helicobacter pylori (h. pylori) infection. suitable for use in both point of care and clinical laboratory settings.
otsuka poconeplus infrared spectrophotometer
nagase singapore (pte) ltd. - microbiology - the poconeplus infrared spectrophotometer is an in vitro diagnostic medical device designed to measure changes in the 13co2 content in breath co2 gas by infrared spectroscopic analysis.
mucosta tablets 100 mg
a. menarini singapore pte. ltd. - rebamipide; rebamipide -
abilify 10mg orodispersible tablets
otsuka pharmaceuticals (u.k. - aripiprazole - orodispersible tablet - 10mg
abilify 15mg orodispersible tablets
otsuka pharmaceuticals (u.k. - aripiprazole - orodispersible tablet - 15mg
abilify 1mgml oral solution
otsuka pharmaceuticals (u.k. - aripiprazole - oral solution - 1mg/1ml
abilify 9.75mg1.3ml solution for injection vials
otsuka pharmaceuticals (u.k. - aripiprazole - solution for injection - 7.5mg/1ml
samsca 30mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 30mg
samsca 15mg tablets
otsuka pharmaceuticals (u.k. - tolvaptan - tablet - 15mg